Showing results (181-190 of 224) with videos related to
Sort By:
Pageof 23
Archives of Cardiovascular Diseases|September 28, 2011
Modelling of blood pressure and total cardiovascular risk outcomes after second-line valsartan therapy: the BSCORE studyRobert Lins, Nicolas Coen, Ann Aerts, et al.Journal of Medical Economics|June 15, 2023
Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in JordanHala H Halawah, Nimer S Alkhatib, Abdulaali R Almutairi, et al.The Annals of Pharmacotherapy|January 14, 2023
Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer PerspectiveShiraz Halloush, Nimer S Alkhatib, Abdulaali R Almutairi, et al.American Journal of Clinical Dermatology|May 29, 2026
Understanding the Clinical Spectrum of the Cutaneous and Acute Hepatic PorphyriasToan N Vu, Sahithi Talasila, George M Jeha, et al.The Annals of Pharmacotherapy|June 14, 2011
Effectiveness of amlodipine-valsartan single-pill combinations: hierarchical modeling of blood pressure and total cardiovascular disease risk outcomes (the EXCELLENT study)Robert Lins, Ann Aerts, Nicolas Coen, et al.Primary Care Diabetes|July 9, 2016
Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study)Michel Hermans, Luc Van Gaal, Ingrid Rézette, et al.The Prostate|March 23, 2019
The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysisMok Oh, Nasser Alkhushaym, Saad Fallatah, et al.Journal of Clinical Nursing|October 6, 2010
Evaluation of the feasibility of a school-based asthma management programme in TaiwanSuh-Hwa Maa, Yue-Cune Chang, Chun-Liang Chou, et al.International Urology and Nephrology|April 21, 2015
Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study)Loreto Gesualdo, Christian Combe, Adrian Covic, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 12, 2019
Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting: a Bayesian network meta-analysisAbdullah A Alhifany, Ali McBride, Abdulaali R Almutairi, et al.Pageof 23